Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_assertion type Assertion NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_head.
- NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_assertion description "[Despite the high incidence of revertant mosaicism (35%) in patients with the genetic skin disease epidermolysis bullosa (EB) due to correcting mutations in the genes COL17A1 and LAMB3, revertant mosaicism has not been described for COL7A1 until recently.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_provenance.
- NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_assertion evidence source_evidence_literature NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_provenance.
- NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_assertion SIO_000772 20574443 NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_provenance.
- NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_assertion wasDerivedFrom befree-20150227 NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_provenance.
- NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_assertion wasGeneratedBy ECO_0000203 NP530506.RAU4IhgbQW63AOzRs-xX4qFc3fNVYJq_ZDSVdv9oudOa0130_provenance.